Загрузка...
High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinoma
BACKGROUND: Glutamine-fructose-6-phosphate transaminase 1 (GFPT1) is the first rate-limiting enzyme of the hexosamine biosynthesis pathway (HBP), which plays a pivotal role in the progression of pancreatic ductal adenocarcinoma (PDAC). Therefore, we investigated the prognostic significance of GFPT1...
Сохранить в:
| Опубликовано в: : | World J Surg Oncol |
|---|---|
| Главные авторы: | , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7849098/ https://ncbi.nlm.nih.gov/pubmed/33517899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-021-02147-z |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|